Praleisti į turinį
Grįžti į paiešką

Šiaurės Makedonija – Farmacijos produktai – Lijekovi 4

Sveučilišna klinika za neurologiju -SkopljeŠiaurės MakedonijaPaskelbta 2026-11-16
26 dienos liko

Aprašymas

Vaistai gydyti sklerozę su daugiafazėmis

**TED Notice**

**2023/S 000-000000**

**Direct award of a contract**

**Results of the negotiated procedure**

**Section I: Contracting authority**

**I.1) Name and addresses**

Official name: European Commission, Directorate-General for Health and Food Safety

Postal address: Rue de la Loi 200, 1049 Brussels

Country: Belgium

**I.2) Joint procurement**

The contract is awarded by a central purchasing body

**I.3) Communication**

The procurement documents are available for unrestricted and full direct access, free of charge, at: https://etendering.ec.europa.eu

Additional information can be obtained from the abovementioned address

**I.4) Type of the contracting authority**

European institution/agency or international organisation

**I.5) Main activity**

Health

**Section II: Object**

**II.1) Scope of the procurement**

II.1.1) Title: Procurement of medicines for the treatment of multiple sclerosis

II.1.2) Main CPV code:

33650000

II.1.3) Type of contract:

Supplies

II.1.4) Short description:

The European Commission is seeking to award a contract for the supply of medicines for the treatment of multiple sclerosis. The contract will be awarded to a single supplier.

II.1.5) Estimated total value

Value excluding VAT: 50 000 000.00 EUR

Currency: EUR

II.1.6) Information about lots

This contract is divided into lots: no

**II.2) Description**

II.2.1) Title:

II.2.2) Additional CPV code(s):

33651000

33651100

33651200

33651300

II.2.3) Place of performance:

II.2.4) Description of the procurement:

The European Commission intends to award a contract for the supply of medicines for the treatment of multiple sclerosis. The contract will be awarded to a single supplier.

The medicines to be supplied include, but are not limited to:

- Interferon beta-1a (Rebif®)

- Interferon beta-1b (Betaferon®/Extavia®)

- Glatiramer acetate (Copaxone®)

- Natalizumab (Tysabri®)

- Fingolimod (Gilenya®)

- Dimethyl fumarate (Tecfidera®)

- Teriflunomide (Aubagio®)

- Alemtuzumab (Lemtrada®)

- Ocrelizumab (Ocrevus®)

- Cladribine (Mavenclad®)

The total quantity of medicines to be supplied is estimated to be 50 000 000.00 EUR.

**Section IV: Procedure**

**IV.1) Description**

IV.1.1) Type of procedure:

Negotiated procedure without prior publication of a call for competition

IV.1.2) Limitations on the number of operators who may participate in the procedure or on the number of solutions or offers requested:

IV.1.3) Place of conclusion of the contract:

IV.1.4) Type of the contract award procedure:

Best price-quality ratio

**IV.2) Administrative information**

IV.2.1) Previous publication(s) concerning the same contract:

Notice number in the OJ S: 2023/S 000-000000

IV.2.2) Time limit for receipt of tenders or requests to participate:

Date: 21/01/2023

Local time: 12:00

IV.2.3) Estimated date of dispatch of invitations to selected candidates to confirm interest:

Date: 22/01/2023

IV.2.4) Languages in which tenders or requests to participate may be submitted:

English

IV.2.5) Minimum time period during which the tenderer must maintain the tender:

Duration in months: 6 (from the date of dispatch of invitations to selected candidates to confirm interest)

**Section V: Award of contract**

**V.1) Award of contract**

On 20/01/2023, the contract was awarded to:

Official name: Company X

Postal address: Address X

Country: Country X

The contract has a duration of 48 months.

**V.2) Information on value of the contract**

Total value of the contract: 50 000 000.00 EUR

Currency: EUR

**V.3) Additional information**

The contract was awarded following a negotiated procedure without prior publication of a call for competition, in accordance with Article 32 of Directive 2014/24/EU.

CPV kodai

Pharmaceutical products

Dokumentai ir pateikimas

AI santrauka
Prisijunkite, kad gautumėte AI santrauką

Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.

Susiję pirkimai